Search Prime Grants

R42DA056255

Project Grant

Overview

Grant Description
Parca (a digital tool) to improve justice and health.
Awardee
Q2I
Funding Goals
TO SUPPORT BASIC AND CLINICAL NEUROSCIENCE, BIOMEDICAL, BEHAVIORAL AND SOCIAL SCIENCE, EPIDEMIOLOGIC, HEALTH SERVICES AND HEALTH DISPARITY RESEARCH. TO DEVELOP NEW KNOWLEDGE AND APPROACHES RELATED TO THE PREVENTION, DIAGNOSIS, TREATMENT, ETIOLOGY, AND CONSEQUENCES OF DRUG ABUSE AND ADDICTION, INCLUDING HIV/AIDS. TO SUPPORT RESEARCH TRAINING AND RESEARCH SCIENTIST DEVELOPMENT. TO SUPPORT DISSEMINATION OF RESEARCH FINDINGS. SMALL BUSINESS INNOVATION RESEARCH (SBIR) LEGISLATION IS INTENDED TO EXPAND AND IMPROVE THE SBIR PROGRAMS TO EMPHASIZE AND INCREASE PRIVATE SECTOR COMMERCIALIZATION OF TECHNOLOGY DEVELOPED THROUGH FEDERAL SBIR RESEARCH AND DEVELOPMENT, INCREASE SMALL BUSINESS PARTICIPATION IN FEDERAL RESEARCH AND DEVELOPMENT, AND FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN THE SBIR PROGRAM. THE LEGISLATION INTENDS THAT THE SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAM STIMULATE AND FOSTER SCIENTIFIC AND TECHNOLOGICAL INNOVATION THROUGH COOPERATIVE RESEARCH AND DEVELOPMENT CARRIED OUT BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, FOSTER TECHNOLOGY TRANSFER BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, AND FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION.
Place of Performance
Rindge, New Hampshire 034615305 United States
Geographic Scope
Single Zip Code
Analysis Notes
Amendment Since initial award the End Date has been extended from 11/30/23 to 04/30/26 and the total obligations have increased 654% from $256,009 to $1,930,450.
Q2I was awarded Project Grant R42DA056255 worth $1,930,450 from National Institute on Drug Abuse in May 2023 with work to be completed primarily in Rindge New Hampshire United States. The grant has a duration of 3 years and was awarded through assistance program 93.279 Drug Abuse and Addiction Research Programs. The Project Grant was awarded through grant opportunity HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (R41/R42 - Clinical Trial Optional).

SBIR Details

Research Type
STTR Phase I
Title
PARCA (a digital tool) to improve Justice and Health
Abstract
PROJECT SUMMARY/ABSTRACT Nearly 4.4 million individuals are on community supervision in the United States, with the majority (about 80%) being supervised under probation.1 Justice involved persons (JIPs) have a 474% increased lifetime experience with heroin, a 303% increased use of OxyContin in the last 12 months, and a 256% increased use in pain medication in the last 12 months, compared to the general population.3 One important step in addressing substance use and addiction is getting individuals engaged in the treatment process, as initiation and retention rates are very low for substance use treatment among this population. Q2i successfully developed the Probation/Parole And Reentry Coach Application (PARCA) technology, which includes a Justice Team (JT) Dashboard connected to a mobile app designed for JIPs. The platform enables JIPs to set and manage their personal goals while assisting them in addressing the social determinants of health (SDOH) in order to facilitate and supplement the substance use treatment process. It provides a step-by-step guide and identifies local services and resources that the JIPs can connect with to accomplish these goals. At the same time, it gives the JT a dashboard that enables greater insight on how a JIP is managing their plan. This increased connection and communication between the JT and the JIP is designed to improve the community supervision process. In this Phase 1/Phase 2 Fast Track STTR application, Q2i’s PARCA platform will be refined and implemented in Dallas and Hidalgo Counties to test its efficacy. The primary goal of Phase I is to enhance the PARCA platform for JIP. The study team will accomplish this by recruiting three sets of 2 PPOs/Case Managers willing to use PARCA with five of their clients who have used any opioids in the last 12 months (total JIPs = 30) for 2- weeks. The team will conduct interviews with PPOs and their clients that will inform our user-centered design iterations. Initial interviews will describe barriers and challenges to successful community supervision including accessing MOUD treatment and how PARCA can be improved to address these challenges. Follow- up interviews will describe feasibility (use of the PARCA platform features) and acceptability (engagement with PARCA platform through user engagement logs) of using PARCA platform to locate and access MOUD treatment. The overall goal of Phase II is to test the relative efficacy of supervision as usual (SAU) and PARCA in helping JIPs under community supervision engage in substance use treatment process and reduce subsequent involvement in criminal behavior. Using a stepped wedge effectiveness design, we will evaluate the PARCA platform across probation/parole officers (PPOs) (N=60), probationers/parolees (N=600). PPOs will be randomized in three clusters of 20 people to utilize PARCA. Lastly, we will assess the acceptability and feasibility of PARCA platform by supervision officers and justice-involved persons (JIPs) and whether PARCA improves the working alliance between supervisors and JIPs.
Topic Code
NIDA
Solicitation Number
DA19-020

Status
(Ongoing)

Last Modified 4/21/25

Period of Performance
5/1/23
Start Date
4/30/26
End Date
67.0% Complete

Funding Split
$1.9M
Federal Obligation
$0.0
Non-Federal Obligation
$1.9M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to R42DA056255

Transaction History

Modifications to R42DA056255

Additional Detail

Award ID FAIN
R42DA056255
SAI Number
R42DA056255-677507735
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Small Business
Awarding Office
75N600 NIH National Insitute on Drug Abuse
Funding Office
75N600 NIH National Insitute on Drug Abuse
Awardee UEI
H7EQKJLW3N11
Awardee CAGE
875D1
Performance District
NH-02
Senators
Jeanne Shaheen
Margaret Hassan

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Institute on Drug Abuse, National Institutes of Health, Health and Human Services (075-0893) Health research and training Grants, subsidies, and contributions (41.0) $256,009 100%
Modified: 4/21/25